10/31/2025Longwood Biopharma Secures Series B+ Funding to Accelerate Innovative ...

10/31/2025Sichuan Biokin Advances 11th ADC Candidate BL-M24D1 into Clinical Tria...

10/31/2025Bayer to Divest Avelox Assets to HSG in Deal Valued up to €260 Millio...

10/31/2025Asia Regenerative Medicine Completes Series A Funding

10/31/2025NMPA Grants Conditional Approval for Lepu Biotech's Becotatug Vedotin

10/29/2025China Issues Guidelines to Strengthen Primary Care Chronic Disease Man...

10/29/2025NHSA Launches Public Consultation Module for DRG Payment Grouping Plan...

10/29/2025CDE Seeks Public Feedback on Draft Guidelines for Master Protocol Drug...

10/29/2025CDE Issues Technical Guidance on Post-Approval Chemistry Changes for S...

10/29/2025CDE Issues Guidance on Age-Friendly Design Principles for Innovative D...

10/29/2025CDE Issues Guidance on Key Elements and Trial Design for Elderly Parti...

10/29/2025CDE Issues Draft Guidelines on Including Geriatric Use Information in ...

10/29/2025NMPA Seeks Comments on Revised GCP Draft for Drug Trials

10/29/2025Pharmaron to Acquire Biortus in China

10/29/2025Immunofoco Raises Series B+ Funding to Advance CAR-T Platforms for Sol...

10/29/2025NMPA Approves Huadong Pharma's Mifanertinib Maleate for EGFR-Mutant NS...

10/29/2025Abbisko Presents Promising Preclinical Data on Novel CDK4/2 Inhibitor ...

10/28/2025NHC Publicizes Fourth Batch of Recommended List of Encouraged Generic...

10/28/2025China Sets Goal to Raise Average Life Expectancy to 80 by 2030

10/28/2025NMPA Issues Technical Guidelines for Shingles Vaccine Clinical Trials

10/28/2025NMPA Seeks Comments on Draft Measures for Drug Quality Sampling and Te...

10/28/2025Over 400 Companies Join China's 11th Round of VBP

10/28/2025Metis TechBio to File China NDA for AI-Designed PBA Drug MTS-004

10/28/2025Innovent's Mazdutide Tops Ozempic in Phase III Diabetes and Obesity Tr...

10/27/2025Hengrui's TROP-2 ADC SHR-A1921 Shows Promising Activity in First-in-Hu...

10/27/2025AstraZeneca Unveils Three Major Initiatives in China

10/27/2025Zai Lab Shares Phase 1 Data for DLL3-Targeted ADC Rivaling Amgen's Imd...

10/27/2025Alphamab Doses First Patient in Phase 1 Trial of PD-L1/αvβ6 Bispecif...

10/27/2025Lanma's LM103 TIL Therapy Moves Into Phase 2 After Promising Phase 1 D...

10/27/2025CytoCares Raises CNY 68M in Series A++ Round Led by Tellgen

Page:8/58 Total number of articles:1718: [First][<<] [6] [7] [8] [9] [10] [>>] [End]